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Ten recommendations for Osteoarthritis and Cartilage (OAC) manuscript
preparation, common for all types of studiesThe aim of these recommendations is a clear, complete, and
unambiguous presentation of data, methods, and results. It is of
paramount importance, and one of the tenets of good research
that presented studies and experiments can be reproduced, and
that the description of their outcome includes sufﬁcient informa-
tion to allow a reasonable assessment of unavoidable limitations
and weaknesses. In one word: transparency. The purpose of the
ten recommendations is to describe what information should be
presented to the reader, and how, for facilitating his or her interpre-
tation of the presented ﬁndings, not to specify how the authors
should evaluate and interpret their data.
Additional guidelines and details are available for manuscripts
presenting speciﬁc types of research, please refer to the Guide for
Authors of Osteoarthritis and Cartilage for further information.
1. State the research question and the purpose of the study. Is the
ambition to describe an observation, to generate hypotheses or
to test a pre-speciﬁed hypothesis?
2. Describe the source of study participants, patients, cadavers,
animals, tissues, cell lines, etc., and how many of these units
that have been included in the study. What inclusion criteria did
you use?How representative is your sample? Towhat population
do you wish to generalize the ﬁndings of your study? Note that
direct generalization to other cases than those studied requires
information on the variability between independent cases. If all
observations have been sampled from one subject, animal or
cell line, direct generalization cannot be made beyond this.
3. When observations can be presented individually, either
numerically or graphically, this should be preferred. In some
cases such presentation could in itself be sufﬁcient as a result
presentation, in other cases it may complement the summary
measures in the manuscript or in a web supplement. When
fewer than four observations are presented, they should as
a rule be described individually, not as an aggregate.
4. When presenting data in aggregated form, always provide the
number of included observations (n) as well as measures of
central tendency (mean, median, etc.) and dispersion (standard
deviation, range, etc.). If repeated measurements or replicates
are used, present both the number of independent samples and
the number of repeated observations per independent sample.
5. Describe all statistical methods in the statistical methods
section, using well recognized terms such as Student’s or
Satterthwaite’s t-test rather than names that are unique to
a particular statistical software package such as “independent1063-4584/$ – see front matter  2011 Osteoarthritis Research Society International. Pu
doi:10.1016/j.joca.2011.07.007groups t-test”. You should always identify the statistical soft-
ware and version used.
6. The validity of the results from statistical tests relies on certain
assumptions being fulﬁlled. For example, Student’s t-test is based
ontheassumptionsof independentobservations,Gaussiandistri-
bution and homogeneous variance. Describe in the statistical
methods section whether you have examined if these assump-
tions are fulﬁlled, how you performed this investigation, and
what the results were. When departures from the assumptions
are detected, a change to an alternative method (for example
a non-parametric) may be necessary to get valid results.
7. Generalizations from observed data are often made using
hypothesis tests. The resulting P-values describe the inferential
uncertainty in terms of risk of a false positive conclusion. It
should be recognized that: (1) tested hypotheses always relate
to the generalization of an observation, never to the observa-
tion itself, (2) that a statistically signiﬁcant ﬁnding is not neces-
sarily practically important, and (3) that a statistically
insigniﬁcant test does not necessarily indicate similarity.
8. Generalizations from observed data can also be made using
interval estimation. Conﬁdence intervals provide more informa-
tion on the inferential uncertainty than is included in a P-value
because they describe a range of plausible and interpretable
values, not just a probability. It is important to recognize that
this range of plausible values represents the uncertainty in
a generalization, not the dispersion of observed data.While stan-
dard deviations and ranges can be used to describe dispersion,
conﬁdence intervals and standard error of the means represent
uncertainty. When this uncertainty is presented in text and
tables, or graphicallywith error bars, Osteoarthritis and Cartilage
recommends using 95% conﬁdence intervals instead of S.E.M.
9. If one-sided statistical tests, one-sided conﬁdence intervals,
Bonferroni corrections, simultaneous conﬁdence intervals, or
other departures from the conventional 5% signiﬁcance and
95% conﬁdence level are used, explain and motivate your
reasons for this.
10. The level of statistical rigor (and remaining inferential uncer-
tainty in the results) should be in parity with the purpose of
the study and the author’s conclusions. For example, a conﬁr-
matory randomized clinical trial has little room for multiplicity
issues arising from the testing of multiple endpoints. If such
issues exist, they should be properly addressed already in the
design of the trial. Hypothesis generating studies, on the other
hand, can be analyzed without concerns for multiplicity, andblished by Elsevier Ltd. All rights reserved.
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descriptive with no need for evaluation of inferential uncer-
tainty. A brief description of the analysis strategy in the statis-
tical methods section will facilitate the reading of the
manuscript. Authors are strongly recommended to save statis-
tical code, output from data analyses, and raw data and raw
images for possible review, should the editors request this.
Adherence to these recommendations will greatly facilitate the
review of yourmanuscript, decrease the likelihood of multiple revi-
sions, and improve the chances of acceptance for publication.
The editors recognize that the recommendations summarized
above will beneﬁt from additional explanations, examples and
discussion. We therefore aim to expand on these topics in future
issues of Osteoarthritis and Cartilage.
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